Last reviewed · How we verify
NCT04586361
Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear
Phase 4 trial testing RegenLab PRP in PRP in 150 participants. Status unknown.
15 September 2021
Quick facts
| Lead sponsor | Kaohsiung Veterans General Hospital. |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 15 October 2020 |
| Primary completion | 15 September 2021 |
| Estimated completion | 15 September 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- RegenLab PRP
- hyaluronic acid (HYALURONIC ACID) — full drug profile →
- normal saline
Conditions studied
- PRP — all drugs for PRP →
- ACL — all drugs for ACL →
- Hyaluronic Acid — all drugs for Hyaluronic Acid →
Sponsor
Kaohsiung Veterans General Hospital.
Who can join
20 and older, any sex, with PRP or ACL. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose: The purpose of this article is to examine the clinical application of PRP and PRP+hyaluronic acid in disorders in the knee. Methods: The study was conducted on 150 adult patients with age over 20 years old affected by unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in three groups, and we treated the group A with perioperative injection of HHA, group B with perioperative HHA+PRP, group C with perioperative normal saline. Follow-up: Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04586361
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for PRP
Currently open trials in the same condition.
- NCT07470359 — Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and With · Phase 2 · recruiting
- NCT06472323 — The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for the Trigeminal Neuralgia · recruiting
- NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
- NCT05412381 — PRP in ACLR to Prevent PTOA · Phase 3 · recruiting
- NCT05279560 — Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation · NA · active not recruiting
Other Kaohsiung Veterans General Hospital. trials
Trials by the same sponsor.
- NCT07278024 — Postbiotic Intervention on Vaginal Microbiota · NA · completed
- NCT07051265 — Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer · NA · enrolling by invitation
- NCT06777758 — Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments · Phase 4 · recruiting
- NCT06803199 — Effects of LH and FSH on Metabolic Regulation in Cumulus Cells · NA · recruiting
- NCT06946888 — Effects of Acupressure on Nurses' Psychological Distress, Depression, Job Stress, Occupational Burnout, and Resilience · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04586361 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Veterans General Hospital.
- Last refreshed: 14 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04586361.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing